Special Considerations for Testing for Extractables and Leachables - - BioPharm International

ADVERTISEMENT

Special Considerations for Testing for Extractables and Leachables

Pharmaceutical Technology



Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Ferdinand Dabu, director of marketing at SGS live at Interphex 2013 about extractables and leachables. In this interview they discuss special considerations for testing for extractables and leachables for both small molecule and biological drug development.
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Personalized Cell Therapy Receives FDA Breakthrough Therapy Designation
July 9, 2014
FDA Urged to Preserve Biosimilar Naming Conventions
July 2, 2014
EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
July 1, 2014
Merck Collaborates with Bionomics on Alzheimer's Treatments
July 1, 2014
FDA Outlines Guidance and Rules for Compounding Drug Products
July 1, 2014
Author Guidelines
Source: Pharmaceutical Technology,
Click here